Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bixby, Dale (VerfasserIn) , Noppeney, Richard (VerfasserIn) , Lin, Tara L. (VerfasserIn) , Cortes, Jorge (VerfasserIn) , Krauter, Jürgen (VerfasserIn) , Yee, Karen (VerfasserIn) , Medeiros, Bruno C. (VerfasserIn) , Krämer, Alwin (VerfasserIn) , Assouline, Sarit (VerfasserIn) , Fiedler, Walter (VerfasserIn) , Dimier, Natalie (VerfasserIn) , Simmons, Brian P. (VerfasserIn) , Riehl, Todd (VerfasserIn) , Colburn, Dawn (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: British journal of haematology
Year: 2019, Jahrgang: 185, Heft: 3, Pages: 595-598
ISSN:1365-2141
DOI:10.1111/bjh.15571
Online-Zugang:Verlag, Volltext: https://doi.org/10.1111/bjh.15571
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15571
Volltext
Verfasserangaben:Dale Bixby, Richard Noppeney, Tara L. Lin, Jorge Cortes, Jürgen Krauter, Karen Yee, Bruno C. Medeiros, Alwin Krämer, Sarit Assouline, Walter Fiedler, Natalie Dimier, Brian P. Simmons, Todd Riehl, Dawn Colburn

MARC

LEADER 00000caa a2200000 c 4500
001 1675902879
003 DE-627
005 20220816220937.0
007 cr uuu---uuuuu
008 190904s2019 xx |||||o 00| ||eng c
024 7 |a 10.1111/bjh.15571  |2 doi 
035 |a (DE-627)1675902879 
035 |a (DE-599)KXP1675902879 
035 |a (OCoLC)1341242512 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bixby, Dale  |e VerfasserIn  |0 (DE-588)1030305978  |0 (DE-627)735014477  |0 (DE-576)378108816  |4 aut 
245 1 0 |a Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia  |b results of a phase Ib trial  |c Dale Bixby, Richard Noppeney, Tara L. Lin, Jorge Cortes, Jürgen Krauter, Karen Yee, Bruno C. Medeiros, Alwin Krämer, Sarit Assouline, Walter Fiedler, Natalie Dimier, Brian P. Simmons, Todd Riehl, Dawn Colburn 
264 1 |c 2019 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 11 September 2018 
500 |a Gesehen am 04.09.2019 
650 4 |a Hedgehog signalling 
650 4 |a leukaemia 
650 4 |a stem cells 
650 4 |a vismodegib 
700 1 |a Noppeney, Richard  |e VerfasserIn  |4 aut 
700 1 |a Lin, Tara L.  |e VerfasserIn  |4 aut 
700 1 |a Cortes, Jorge  |e VerfasserIn  |4 aut 
700 1 |a Krauter, Jürgen  |e VerfasserIn  |4 aut 
700 1 |a Yee, Karen  |e VerfasserIn  |4 aut 
700 1 |a Medeiros, Bruno C.  |e VerfasserIn  |4 aut 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Assouline, Sarit  |e VerfasserIn  |4 aut 
700 1 |a Fiedler, Walter  |e VerfasserIn  |4 aut 
700 1 |a Dimier, Natalie  |e VerfasserIn  |4 aut 
700 1 |a Simmons, Brian P.  |e VerfasserIn  |4 aut 
700 1 |a Riehl, Todd  |e VerfasserIn  |4 aut 
700 1 |a Colburn, Dawn  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 185(2019), 3, Seite 595-598  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia results of a phase Ib trial 
773 1 8 |g volume:185  |g year:2019  |g number:3  |g pages:595-598  |g extent:4  |a Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia results of a phase Ib trial 
856 4 0 |u https://doi.org/10.1111/bjh.15571  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15571  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190904 
993 |a Article 
994 |a 2019 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 8 
999 |a KXP-PPN1675902879  |e 3511633907 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Bixby, Dale","given":"Dale","role":"aut","family":"Bixby"},{"display":"Noppeney, Richard","role":"aut","given":"Richard","family":"Noppeney"},{"given":"Tara L.","role":"aut","display":"Lin, Tara L.","family":"Lin"},{"family":"Cortes","display":"Cortes, Jorge","role":"aut","given":"Jorge"},{"role":"aut","given":"Jürgen","display":"Krauter, Jürgen","family":"Krauter"},{"display":"Yee, Karen","given":"Karen","role":"aut","family":"Yee"},{"family":"Medeiros","role":"aut","given":"Bruno C.","display":"Medeiros, Bruno C."},{"family":"Krämer","role":"aut","given":"Alwin","display":"Krämer, Alwin"},{"family":"Assouline","role":"aut","given":"Sarit","display":"Assouline, Sarit"},{"given":"Walter","role":"aut","display":"Fiedler, Walter","family":"Fiedler"},{"family":"Dimier","display":"Dimier, Natalie","role":"aut","given":"Natalie"},{"given":"Brian P.","role":"aut","display":"Simmons, Brian P.","family":"Simmons"},{"display":"Riehl, Todd","given":"Todd","role":"aut","family":"Riehl"},{"family":"Colburn","given":"Dawn","role":"aut","display":"Colburn, Dawn"}],"name":{"displayForm":["Dale Bixby, Richard Noppeney, Tara L. Lin, Jorge Cortes, Jürgen Krauter, Karen Yee, Bruno C. Medeiros, Alwin Krämer, Sarit Assouline, Walter Fiedler, Natalie Dimier, Brian P. Simmons, Todd Riehl, Dawn Colburn"]},"note":["First online: 11 September 2018","Gesehen am 04.09.2019"],"relHost":[{"pubHistory":["1.1955 -"],"part":{"issue":"3","extent":"4","pages":"595-598","text":"185(2019), 3, Seite 595-598","year":"2019","volume":"185"},"language":["eng"],"title":[{"title":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology","title_sort":"British journal of haematology"}],"note":["Gesehen am 08.05.08"],"corporate":[{"role":"isb","display":"British Society for Haematology"},{"role":"isb","display":"European Hematology Association"}],"disp":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia results of a phase Ib trialBritish journal of haematology","id":{"issn":["1365-2141"],"zdb":["1475751-5"],"doi":["10.1111/(ISSN)1365-2141"],"eki":["269758941"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"269758941","origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","dateIssuedDisp":"1955-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedKey":"1955"}],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]}}],"physDesc":[{"extent":"4 S."}],"id":{"eki":["1675902879"],"doi":["10.1111/bjh.15571"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"recId":"1675902879","language":["eng"],"title":[{"title_sort":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia","subtitle":"results of a phase Ib trial","title":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia"}]} 
SRT |a BIXBYDALENSAFETYANDE2019